Navigation Links
SCRIP, the Leading Pharmaceutical Magazine in the World Crowns Glenmark as the "Best Pharma Company in the World - SME" and the "Best Company in Emerging Markets" at the SCRIP Awards 2008 in London
Date:12/11/2008

    MUMBAI, India, December 11 /PRNewswire/ --

    - SCRIP Awards Recognises the Best and Brightest in the Pharmaceutical
      and Biotech Industries Worldwide

    - Glenmark is the Only Indian Company to Have Received This
      Prestigious Recognition

The best and brightest of the pharmaceutical and biotech industries were celebrated at a glittering ceremony in London at the 2008 SCRIP Awards hosted by the leading UK broadcaster Peter Sissons on December 10th. At this award ceremony, which is one of the most prestigious recognitions for pharmaceutical organisations worldwide, Glenmark was recognised as the Best Pharma Company in the World - SME" and the "Best Company in Emerging Markets". SCRIP is the leading pharmaceutical magazine in the world which organises this award ceremony where all the big names in the pharma world not only compete for this recognition but also attend this award ceremony.

In a press statement issued by SCRIP, it states, 'Glenmark crowned a busy year by winning the SCRIP Awards for Best Company in an Emerging Market and Pharma Company of the year for small and medium-sized enterprises. In his judging, Dr. Richard Barker said the Indian firm, "scored well on almost all dimensions, showing dramatic growth in its generics business plus a promising early stage pipeline in some high potential areas for branded medicines." Other judges agreed, "Glenmark is a phenomenon!" said Dr. Viren Mehta.' The article further mentioned, 'While no company swept the board in 2008, Glenmark Pharmaceuticals and GlaxoSmithKline Biologicals were the night's biggest winners, each garnering two awards.'

Mr. Glenn Saldanha, MD & CEO, Glenmark Pharmaceuticals limited who was present at the award ceremony mentioned, "This is a very big honour for our organisation. We are extremely glad that at this award ceremony which had all the biggest names in the pharma world attend and participate, Glenmark has triumphed. Most importantly, we are glad to showcase to the world that an Indian company can do pioneering work in the area of innovative research and consistently discover new chemical and biological entities for chronic diseases in novel therapeutic target areas."

For more information on the SCRIP Awards, please log on to http://www.scripnews.com/top_news/2008-scrip-awards-celebrate-industrys-achie vements-2197

(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

    For further information, please contact:
    Jason D'Souza / Medha Satam
    Glenmark Pharmaceuticals Limited
    Tel: +91-22-40189919 / 40189993
    Email : jasond@glenmarkpharma.com
    Web :http://www.glenmarkpharma.com


'/>"/>
SOURCE Glenmark Pharmaceuticals Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Leading Canadian Scientist to speak at UN Climate Change Conference
2. TRIDELITY Display Solutions Partners With Two Of The World's Leading Imaging Software Companies
3. Stem Cell Sciences Licenses Stem Cell Technology to Leading Provider of Genetically Modified Models for Pharmaceutical Research
4. MGuard(TM), InspireMDs Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008
5. Patent Technologies Keep CGMT in a Leading Position in the Industry
6. Leading Heart Specialist Joins Duska Therapeutics as Scientific Consultant
7. Dynamic Signs Asset Acquisition Deal With Cannex and Brings Onboard Leading Medical Cannabis Research Scientist Dr. Robert Melamede, Former Chairman of the Biology Department, University of Colorado
8. CORD:USE Cord Blood Bank is Proud to Announce that Cord Blood Pioneer and Leading Transplanter Dr. Eliane Gluckman has Joined its Team
9. ThalesNano, Inc. Forms Collaborations with Leading US Universities based on the Award Winning H-Cube(R) and H-Cube Midi(TM)
10. Trusted LASIK Surgeons Welcomes Leading LASIK Eye Surgery Expert, Inventor David Huang, M.D., Los Angeles, to Its Unique Lasik Directory Service
11. Arius announces leading independent proxy firm, RiskMetrics ISS Canada, recommends shareholders vote for the arrangement involving its acquisition by Roche
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator (YI) ... of the Class of 2016 were selected from a pool of 128 applicants ... the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... Durham, NC (PRWEB) , ... June 23, 2016 , ... ... Odense University Hospital in Denmark detail how a patient who developed lymphedema after being ... (fat) tissue. The results could change the paradigm for dealing with this debilitating, frequent ...
Breaking Biology Technology:
(Date:4/28/2016)... GOTHENBURG, Sweden , April 28, 2016 ... 1,491.2 M (139.9), up 966% compared with the first quarter of ... Operating profit totaled SEK 589.1 M (loss: 18.8) and the operating ... SEK 7.12 (loss: 0.32) Cash flow from operations was ... , The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/19/2016)... The new GEZE SecuLogic access ... "all-in-one" system solution for all door components. It can ... door interface with integration authorization management system, and thus ... minimal dimensions of the access control and the optimum ... offer considerable freedom of design with regard to the ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
Breaking Biology News(10 mins):